The estimated Net Worth of Jeffrey P. George is at least 241 千$ dollars as of 12 June 2024. Mr. George owns over 7,777 units of Amneal Pharmaceuticals Inc stock worth over 129,162$ and over the last 5 years he sold AMRX stock worth over 0$. In addition, he makes 112,163$ as Independent Director at Amneal Pharmaceuticals Inc.
Sign up
Mr. George AMRX stock SEC Form 4 insiders trading
Jeffrey has made over 12 trades of the Amneal Pharmaceuticals Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently he exercised 7,777 units of AMRX stock worth 65,016$ on 12 June 2024.
The largest trade he's ever made was exercising 80,128 units of Amneal Pharmaceuticals Inc stock on 9 May 2023 worth over 669,870$. On average, Jeffrey trades about 16,764 units every 88 days since 2019. As of 12 June 2024 he still owns at least 15,450 units of Amneal Pharmaceuticals Inc stock.
You can see the complete history of Mr. George stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Jeffrey George biography
Jeffrey (Jeff) P. George serves as Independent Director of the Company. Jeff George has nearly 20 years of global healthcare and corporate leadership experience. He is currently the Managing Partner of Maytal Capital, a healthcare-focused private equity investment and advisory firm he founded, and an Operating Partner at Revival Healthcare Capital, a medical device-focused private equity firm. Between 2008 and 2016, he served on the Executive Committee of Novartis Group AG, one of the largest global pharmaceutical companies, first as Division Head and CEO of Sandoz, Novartis’ $10 billion generic pharmaceuticals and biosimilars subsidiary, and then as Division Head and CEO of Alcon, Novartis’ then $10 billion branded eye care subsidiary. In both roles, he was responsible for leading over 25,000 associates globally across more than 160 countries. More recently, he served as CEO and board member of Performance Health, the largest global manufacturer and distributor of products to the physical therapy and rehabilitation markets.
What is the salary of Jeffrey George?
As the Independent Director of Amneal Pharmaceuticals Inc, the total compensation of Jeffrey George at Amneal Pharmaceuticals Inc is 112,163$. There are 14 executives at Amneal Pharmaceuticals Inc getting paid more, with Andrew Boyer having the highest compensation of 3,113,080$.
How old is Jeffrey George?
Jeffrey George is 46, he's been the Independent Director of Amneal Pharmaceuticals Inc since 2019. There are 18 older and 4 younger executives at Amneal Pharmaceuticals Inc. The oldest executive at Amneal Pharmaceuticals Inc is Shlomo Yanai, 67, who is the Independent Director.
What's Jeffrey George's mailing address?
Jeffrey's mailing address filed with the SEC is C/O 908 DEVICES INC., 645 SUMMER STREET, BOSTON, MA, 02210.
Insiders trading at Amneal Pharmaceuticals Inc
Over the last 7 years, insiders at Amneal Pharmaceuticals Inc have traded over 867,197,480$ worth of Amneal Pharmaceuticals Inc stock and bought 3,818,425 units worth 12,997,905$ . The most active insiders traders include Gp A, Llcbonderman Davidcou...、Holdings, Llc Aphc、International Ltd Fosun. On average, Amneal Pharmaceuticals Inc executives and independent directors trade stock every 18 days with the average trade being worth of 3,857,739$. The most recent stock trade was executed by Andrew S Boyer on 14 August 2024, trading 62,711 units of AMRX stock currently worth 491,654$.
What does Amneal Pharmaceuticals Inc do?
an american pharmaceutical company, amneal develops and produces affordable medicines. the company was built upon a family tradition of quality and integrity. everything amneal does, across the full spectrum of its business, is in service to these guiding principles. amneal is committed to constantly elevating and refining the value it delivers to its customers and patients around the globe.
What does Amneal Pharmaceuticals Inc's logo look like?
Complete history of Mr. George stock trades at Amneal Pharmaceuticals Inc、908 Devices
Amneal Pharmaceuticals Inc executives and stock owners
Amneal Pharmaceuticals Inc executives and other stock owners filed with the SEC include:
-
Andrew Boyer,
Executive Vice President - Commercial Operations -
Chintu Patel R.Ph, R.Ph.,
Co-Founder, Co-CEO & Director -
Nikita Shah,
Chief Human Resource Officer, Senior Vice President -
Andrew S. Boyer,
Exec. VP & Chief Commercial Officer of Generics -
Anastasios G. Konidaris,
Exec. VP & CFO -
Joseph Todisco MBA,
Exec. VP & Chief Commercial Officer of Specialty -
Nikita Shah,
Exec. VP and Chief HR Officer & Strategic Planning Officer -
J. Kevin Buchi,
Independent Director -
Ted Nark,
Independent Director -
Emily Alva,
Independent Director -
Gautam Patel,
Director -
Chintu Patel,
Co-Chief Executive Officer, Co-Founder, Director -
Chirag Patel,
President, Co-Chief Executive Officer, Director -
Paul Meister,
Independent Chairman of the Board -
Shlomo Yanai,
Independent Director -
John Kiely,
Independent Director -
Jeffrey George,
Independent Director -
Chintu Patel R.Ph., R.Ph,
Co-Founder, Co-CEO & Director -
Chirag K. Patel,
Co-Founder, Co-CEO, Pres & Director -
Joseph Todisco,
Senior Vice President - Specialty Commercial -
Apurva Saraf,
Senior Vice President - Corporate Development -
Joseph Greer,
Senior Vice President - Global Quality Management -
Stephen Manzano,
Senior Vice President, General Counsel & Corporate Secretary -
Sanjay Jain,
President - India -
Anastasios Konidaris,
Chief Financial Officer, Senior Vice President -
Jason B. Daly Esq.,
Sr. VP, Chief Legal Officer & Corp. Sec. -
Dr. Nikunj Patel,
Head of Ops & Exec. VP of Amneal Pharmaceuticals (India) Pvt Ltd -
Sanjiv Patel,
Sr. VP of Operations -
Stephen J. Manzano,
Sr. VP, Gen. Counsel & Corp. Sec. -
Anthony DiMeo,
Sr. Director of Investor Relations -
Sheldon Hirt,
SVP, GC & Corp. Sec. -
Jean Selden Greene,
Director -
Holdings, Llc Aphc,
10% owner -
Robert L Burr,
Director -
Bryan M. Reasons,
CFO -
Robert A Stewart,
President and CEO -
Dharmendra Rama,
Director -
Janet S. Vergis,
Director -
Peter R Terreri,
Director -
Paul Bisaro,
Executive Chairman -
David A Buchen,
SVP, Chief Legal Officer -
Todd P. Branning,
SVP and CFO -
Pradeep Bhadauria,
SVP, Chief Scientific Officer -
International Ltd Fosun,
10% owner -
Gustavo Pesquin,
See Remarks -
Gp A, Llcbonderman Davidcou...,
-
Tasos Konidaris,
Executive Vice President & CFO -
Jason B. Daly,
SVP, Chief Legal Officer -
Deborah M. Autor,
Director -
Dipan Patel,
-
Tushar Bhikhubhai Patel,
10% owner